ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T...

15
!" #$ %& % %’ ()) * +,- ( ) ./0 .12 ) 4 .152 ( !"# ( !" #! $!% &%’( )*+ ,#- &%’( $&#- ./0’ 12 ./0’1- 3445" ’6 ( ’6 1 $ )*+ $&#718( $ ./0’ 3445" ( )*+ ,#- 9:06 1 ’ !" #! $!% &%’ -#- "&6 $;:- . <=:6 . : ?@( -1( A B A CD;01 !" E $ )*+ $&#718( $ ./0’ 3445" ’6 1 !" #! $!% &%’( )*+ ,#- 9:06 1 ’ F e-mail: [email protected] $% &’ : )* !+ , ! ,* & -./ 0 1 . -3 45 67 , ! 8," &9/ !:0 !; $ 45 : < ! -3 - =/ 15 . )* > +>,7 ?@ ;A & &5 ! BCD 1 * . * >7 & E!A F9;G 4A1 F’’" !H4 0 !I 1 . $ >7 & -:/ ; = $5 8J &401 ; EK4 .L M ’; C 4* . ’; !N>C !I 1 / . -3 E1 > +>,7 O $?7 &5 !1 K4 E445 0 ;A & 4 E 1 4A1 . M 7 & -4 P Q’; R7 !ST E > MHA KC R7 ;A & ! 1 * . ! &9;G !H4 - E . M , &5 N: - !:U E !+; 1 ! !A $N V FH5 ! : < . .$*G 2/1 : H- I -J <$6 B"1( KL ( 9/ 5 M6 046 I : N / N / NE J@ I P : / / NQ R( P 046 M : S / / NQ 6$46 T6 I ’6 B"U - ;+ I $% . 16 WXS 6 Y- I Z- *6 1 $- SN 2[ A . ’- Z- *6 $;:- B" 1 6 < " % \WQ 1$J QN - Z- *6 $;7A I @6 . ,W H- I ^% I6146 I I H- B" <* &*+ <@A 1 B0:- 6 _#6 .7 % . D . 1 $ ‘J6 B0:- I6146 6 *J6 B 1 % <* a%" b’ .7 6 cZJ ’*2 =67 B0:- $;; $T 01 C 1 . <* &*+ B0:- I6146 -U .7 - 1 $% dTe $;; *46 B0:- I6146 $;-" $; b’ D;6 6 L 9:06 <@A 1 A - % . E H- I ’- 2$- C C-/ ‘6+ 1@+ I f" . Q,g ‘0 B7 0$6 .D:h B4456 40 . i H- I ./0’"( $- 3-J $% :- % [ D E "-J $; &; " Downloaded from ijem.sbmu.ac.ir at 8:28 +0430 on Thursday August 27th 2020

Transcript of ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T...

Page 1: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

���� ��� � �� �� ��������� � ��� ����� ��� ����� � ��� �� ��� � �!��" #��$ %�&��

%�� %��'� (�)�) ��*�+,- (��)./0 �.12 )��4 � � .152(

��� �� ��� �� � ���� �� ��� ����� ��� ��������������

���� �� � !���"#

���� ����� ������������ ������ ���� ���� ��

(���� � ����!" ���#!� $�!% �&%'( )�*+ ��,#-�� ��&%'( �$&#-�� �./�0� '�� �1�2 �./�0� '��1��- 3�4�45" '��6�('��6

�1�� �$� )�*+ �$&#718( ��$� ./�0� '�� 3�4�45" ( )�*+ ��,#-�� �9:�0����6 1 ' � ���� � ����!" ���#!� $�!% �&%' �-�#-

��"�&6 �$;: �- .<�=:6 .:?@( ��-�1�( �����A �B� �����A �CD;01 ����!"�E�$� )�*+ �$&#718( ��$� ./�0� '�� 3�4�45" '��6 �

�1�� ��� � ����!" ���#!� $�!% �&%'( )�*+ ��,#-�� �9:�0����6 1 ' � ����� ���� ����Fe-mail: [email protected]

$��%�

&��'�:�)��* �� !+� � ����,� ����!� �,* & -�./ � ��0� ��1�� .� -3 ��45 � ��� ����� 6��7 ��,� ���

!� 8�,"� &9��/ � � !:0 !;��$� �� ��� ���� � �45����: ��< !�� ��� -3 -��� ��� =���/ ��1�5 .��� � ���

�)��*�>� ��+>,7 ?�@� � ��;�A�� & ����'� � &5 ��� � ��� ��� ����!� BCD� �� ��1��* .���*� �>7 &

�� E!��A�� F�9;�G��4�A1 F�'�'"� ��� !H��4� �0 � � ��� !����I ��1 .$�� �>7 & -�:���/ ��;�� =� $���5 8J�

&4�01��;�� EK��4� ���.L� �M� � ��� ��';� ��� ��C����4*� .�� ��� � ��� ��';� ��� !N>�C� !����I ��1���/�

��� .-3 �� ���� E�1�>� ��+>,7 ���O� � $�?7 &5 !��1K��4� E�445 ����� 0�� ��;�A�� & ����'� �4���� E�� ��1 ��

�4�A1 .����� ��� M� ��� �� � �7 & �������������� -��4�� �� P���� � ��Q�';� R7� ��� �� !��ST ��� E

�>� MHA� K��C� R7� �������������� � ��;�A�� & ����'�!� �� ��1��* .����� ��� !� ��� ���

&9;�G� ��� !H��4� � -��� �� E�������������� ��� � ��� ����� .M� ��,�� ������ ��� �� &5 �N: -����

�!:U�� E������������� ��� � ��� !+�;� ��� ��1�!� � ��� � !��A�� $��N��� ��� � ��� �V F�H�5�� !�� � �����

���: ��<.

.$�*G ��2/�1:H�- I�� � ��-���J <$6�B��"1���(��� �K�L �( 9 /� �� ��5� M�6 ��0�46 I�� �� :�N/N/NE��J@�� I�� �� P:�//NQ R( P�0�46 M� :S/�/NQ

�6$46

�������T6 I�� � ��'�6 B �"U�� �� �-�� ���;+ ��

I� �$%.��1�6��WXS �6 Y-� I�� � �� �Z- ���*�6 1 $-��

SN ��2[ ��A .����� �� '�- �Z- ���*�6$;�:�- ��� B���" 1

�6 <� �" �� ��%�\WQ �1$J �QN� ��-� �� �Z- ���*�6

��� $;7��A I�� � �� @��6.�,W

H�- I�� ��^ �% �� I61�46 �� �� I� I�� � H�- B �"

<�* ��&*�+ <@�A� 1 B�0�:-��6 _�#6 ��� .�7��% .

��D � .����� �1�� � �$��� `J��6 �� B�0�:-� �� I61�46

�6�*J�6 B � �� 1 ��%�<�* a%�" b �'�� �� ��� .�7

�6 cZJ �� '��*2 ����=6�7 �B�0�:-�$;;��� $T� �01 C �

��1� .<�* ��&*�+ �B�0�:-� �� I61�46 �-U� ��� .�7

��- 1 �$% d�Te $;;� �*��46 B�0�:-� �� I61�46 �� $;-��"

$;� b �'�� �� �D;6 �� �6 ���L 9:�0����6 <@�A� 1 ��A -

��%.E

H�- I�� ��'�- �2$-� C� �� �C��-/ `6�+ �� �1@+

I� f��"�� ��.Q,g`�0� B��7 ����0$6 .�D�:h �� B�4456

�40� .���iH�- I�� ��./�0� '���"�( �� $-��� 3�-���J ��

�$%�� ��:-� �� ���% �[ ��D �E�� �"�-���J $;��� �� �&; � �"

�����

����

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 2: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� Wg

9 /� �� �6 � R�" U�� ���L �� � �R���A M��2 �� �$;;�

��A �$;7� ��#- �� $-��� �T�� '��*2 �01 U�� B�0�:-� .

B�0�:-� �� I61�46I�.S3�-���J B � ���b �'�� aj

���� .�" .k��� �� ��� � ���L l�m6 `�0� �� $ �:�*2

.�7$�� ����$�:�� 1 �����6 b �'�� �� K�L$7�F

�j�1 �� '��*2 �-@n+ 1 .$�� I%���� B ����;� .

�6 ��A B�0�:-� b �'�� �� �D;6 1 ���� b7�� B�0�:-� -

��1$56 �� �� '��*2 aj $-���� �" ��%���� �,- �T�� ..X

��B��"1���(��� �� �$% _�#6 ��%R2 3�T0�j6 i)STZ(<�* .1� ����6 3��p����� ��� .�7.Np�PPP �

�� ��"STZ�j��� ���4�:6 .����� �[ �1� ���.�� ��

H�- I�� � .�40� .��� �[ .U�� .�7�1� �� ���6 ���Z�� -

��%.E"`6�+ 1� B � q����9 /� �;T B� �( �1� 1 K�L�(

STZ�6 �H�- I�� � .�40� r+�� $-��"���% ��2$-�h ��.S

<$6 �L�2��T0�j6 .��� .�� � �-���J .�7 .��h1 I�� �

�����9 /� <$6 I��#�( 1 H1�% .�,0� �6� 1 K�L�(STZ

)HFD-STZ(��:-� �� �;�0�� I�Te1 �� .�� � �1$J �"

C �'-I�g<$6 B � �" I� �$% r+�� `6�+ B��7 1�

^ �% H�- I�� � �-���J <$6 B �"�$%��.\ �� .���:� ��

<$6 �" I� ���- �, � .�7STZ 1 ��% s �'" U�� �1� ��

<�* q ��" I*+ �� ��#�� �$% ��D � ��:�*2�t�7 .�7

B�0�:-� �� I61�46 �" I���.g�T0�j6 B � l$7��1�6

�40� .��� ����2 3��� 3�T0�j6iH�- I�� �����Z�� ��

1 K�L�( 9 /� ��STZ ��� .

<$6I�� � �-���J .�7

�*� �� ������� ��h1 I�� � �-���J <$6 H�- 1� :<$6

���D" <$6 1 �&��-/. ���D" <$6�1 ��[ �k��� `���

����� �"I�.,� �� ����% ���6 �� ���Z�� �� ���D" <$6

9 /� ����" �6 ��D � �J��h `�+ � 1 � �R���%.,W H��-�

<$6�� $;"���+ ���D" .�7 :� 1 ��:��0[ s �'"STZ ��

�.����- ��1�E �k��&-�( �� ���:� B�%����Q �� � R�"

`A�� $%� <@�A� �K�L�( � �R� 9 /� ���J� l�m6

����1��uSTZ�W,g �3�6�"�*2 9 $�-�6 s �'"W,Q

$�6[ B�"�&�-uSTZS,X 1.HFD-STZS���6 B � ���� R�"

���J� `A�� $%� <@�A� �K�L�( � �R� 9 /� �� l�m6

����1��uSTZ 1 3�6�"�*2 9 $�-�6 s �'" �HFD-STZ

i- Streptozotocin

�6 '�- B�0�:-� �� I61�46 r+�� �*�� �28 1 �� $-�%

H�- I�� ��I� ��:-� ��.N

�-���J <$6HFD-STZ H�- I�� � v�40� I!h�

<$6 B � ���r+�� K�L�( � �R� 9 /� �� � R�" ��D �

s �'" 1 B�0�:-� �� I61�46STZ &*�+ <@�A� r+��PPP ��

<�*7PPPP�6 ��� .���% .<$6 B ��w�" ��� B�01� .���

$ �ii$% x�j6 b-���&�7 1.�[�� �"�-���J �� $;��� �� �7

9 /� ���6 � R�" K�L�($-$%�U�� B�0�:-� M��2 �� aj

�28 1 ���7 �� ��� �T�� '��*2 �01 B�0�:-� �� I61�46

H�- I�� � ����-�:-�I� .�[�40� .��� �7i�� I61�46

3$6 �� �� 3�-���J �B�0�:-��� R�" K�L�( 9 /� �� ��Z7

$-��� .K�L�( 9 /� �� �1�2 ����1�2 �� �: �46 ��$7�% �

���� b �'�� '��*2 ����=6�7 cZJ .��� B�0�:-� a%�"

��� .� ��%�- q% C �� $T� 3�-���J �Q\�*�6 .��� �� )�2

��$� ��1 )�2�*�� �7STZ �6� $ �1 s � �� I�� ��

1 $-���Ws �'" �� $T� �1�STZ �'��*2 �6� aj �.�"

$ �:�*2���$-� ���[ K�L $�� 1�[ y�( 1 .��2 �� �7

$% ���� I�� � $e .�71���.Sz -�� �[ �� $T�iii 1

d*��6 .�7�1� b-���&�7STZ K�L �( 9 /� ����7 �� ��

�40� I!hi.�7�1� �� $% _�#6 1 $-��� ���� I�� �

B� �(STZ��28 1 H�- I�� � .�7��[ .U�� .�7�1� 1�

�28 1 H�- I�� � .�7�6 ��#- ��$;7�.N

z-�� 1 $ � �� $T��<$6 B � �� ���Z�� �� .�� � 3�T0�j6

�[ �� 1 I��2 3��� B�0�:-� �� I61�46 $� {" I!h �7

_A�%HOMA-IRiv�`�5" I:" 1 '��*2 `�5" I:"

$% ���� B�0�:-�.N _A�%HOMA-IR `��J �� ��

'��*2 K�e)�*�6 ���0 �� <�6 (B�0�:-� 1)�� $J�1 1�&�6

�*�6 ���0 (�$+ �� 9�:4" ��%�-Q/�����6 I�$ [��1�2 ��

�1�2 �� I�:- ���� �$7�% b7�� �,-��� �� ��� ��#��

I��:J B�0�:-� ��I�.N,�\ �T0�j6 �� w�" �� .�

�&1��-�"[vI��2 3��� b-���&�7 1�9 /� �� � R�"

3$6 �� � �!;" �� K�L�(W�� ��Z7PPP _A�% b �'

HOMA-IR �6��� 13$6 �� K�L�( 9 /� .N1 ��Z7

97 s �'" B�;LSTZ 1 _A�% B � ��#�� b �'�� r+��

��� �$% B�0�:-� �� I��:J ��#�� b7��.�\

ii -Reed iii -Zhang iv -Homeostasis model assessment- insulin resistance resistance v -Atanasovska

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 3: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

WS �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

�1�2 �'��*2 `�5" I:" �� �j��� ������ � .�7�'��*2

B � '�- '��*2 ' �D" �� $T� 1 $;�%�� � U�� �Z� ��6�

1 ���� b �'�� ��'�6�U�� ��;|�7 '�- ' �D" �� $T� I+�

��� �$-�6 �����\ <��;� �1�2 �� I�:- �[ �;5;6 � � aj 1

'��*2 `�5" <@�A� �,-�#- �� ��� ��2�'�I�.N,�\

3�-���J ��A '��*2 aj '�- B�0�:-� `�5" I:" ��

���� b7�� I+� �� B�0�:-� s �'" �� $T� 90� ���� �6�

�,�:7[ �� � ���� � 3�-���J ��$% 9� 3$6 �� ��J � 1

W\ �4���I%�$- ��h1 �#7��.N,�

���$-� �� 3�T0�j6 ��#�� �`�+ �� �� ��%�- ��A $;� .��2

�6 ���Z�� ����J �$% ���� � ���T6 ���;+$;;� .��

d*��6 3�T0�j6����$-� �� ��A $;� .��2��" �1��$T� ��6

s �'" ��STZ I� �$% )�D-����Z7 C 3�T0�j6 ��#�� �6�

s �'" �� $T�STZ ����2 ���$-� �� $;�$-�.

<$6 q �T6 1 � �'6HFD-STZ <1$h �����1[ �$%

I�.

<1$hu�28 1 ���� � <$6 .�7HFD-STZ*

� �'6 q �T6 8 1�2�, � .�7

�28 1 �� ���� ���% H�- I�� � �&�0����6 .�7���

��:-�g

��1��-U� v�40� .W.�" b �'�� .�7$�� 1 <1��:*� �$ �:�*2

��A ���[ K�L�\

�40� ���� ����� 1 ��[i���� .��� q�;6 1 I�� �

H�- I�� � ./�0� '���"�(�g,S

C�:��" �p�STZ I��� .1� .�7

��*� $;-�6 �, �E

B�0�:-� aj b7��g,Egb �'�� 1

�* ��&�*2 B���*2��7�,Eg

I�� � ��6�� I!h � 1��� 3�����" ���� .��� q�;6

H�-�g

u�$� ��1 ����" )$+ � b �'��N,�\,Eg

�$% ��D � ��:�*2�t�7 ���� ��$ �(Nu�1�*&�1�"[ ��D �\

�40�iB�0�:-� �� I61�46g,Nuu

HFD-STZ* :B�1���(��� P K�L�( 9 /�

<$6 B ���28 1 H�- I�� � C�0����6 .�7��� �-�:-�

���� �6 ���� k��� �� 1 ����� I*+ �� 1.��� �[ �� ���"

��� ���Z�� I�� � $e 3�����" ����.g97 �� �& B�;L

8 1�2!6 .�7I���$ �( ��:�*2�t�7 ��D � �<$6 B � 9.��

�T0�j6 �I��2 3��� b-���&�7 1 z-�� w�" �� .�

3$6 �� �� �"�-���JE1 ���� � R�" K�L�( 9 /� �� ��Z7

W\ �*�6 �$� ��1 )�2�*�� �7 .��� �� )�2STZ �� ��

��A $;� ��'�6 �$-��� ���� I�� �� ���Z� `A�� 3���

��%�-E�"X��Z7 s �'" �� $T�STZ �� 1 I��p }�� �4"

��1$56 .�Q� �*�6 �� )�2�*�6 $� ���0 ���.N 97�� B�;L

�T0�j6 .�$-��i-���&�7 1b3$6 �� �� �"�-���J �E�� ��Z7

1 ���� � R�" K�L �( 9 /�WQ�*�6 )�2�*�� �7 .��� �� )�2

�$� ��1STZ ���� I�� �� ���Z� `A�� 3��� �� ��

$;� ��'�6 �$-��� " ��%�- ��A��Z7 �� �( �.E��1$56 �� .

W\\ �*�6 �� )�2�*�6 $� ���0��� .��

i -Ratna S. Danda

K�L�( � �R� 9 /�

� B�6{" I!h 3�T0�j6 ��M1� 1� �� K�L�( � �R� 9 /

� �� I� �$% ���Z�� $�0�" '���6 �� ���6[ 3��� ��

�$;;� �$% .��$ �A )�� ?���A .$-�����L � 1PPP �� �� �

���� ���e� �0��T6 .�R� ���$-.T0�j6 ��PP�w�" �� .�

1�ii 3$6 �� �� �"�-���J �I��2 3��� b-���&�7 1S

�� K�L�( 9 /� �� ��Z7QX� R�" ���L �� .�0�� $���

1 �����Q�*�6 �$� ��1 )�2�*�� �7 .��� �� )�2STZ ��

��A $;� �$-��� ���� I�� �� ���Z� `A�� 3��� ��

.��%�-WQW �*�6 �� )�2�*�6 $� ���0 B�0�:-� 1�1�&�6

�� $J�1�*�6 $� ���0 ��'�6 1 $;�%��HOMA-IR �[�� �7

���g�� ���� b �'���.�W 97�T0�j6 �� B�;L 1 B�7�% .

�� K�L�( 9 /� �� � R�" �b-���&�7E\.�0�� $���

3$6 �� ���L �� ���� ���1 ��Z7E\�*�6 )�2STZ ��

�$� ��1 )�2�*�� �7 .������'�6 �� ��A $;� b �'�� r+��

EgN �*�6 )�2 ���*�6 $� ���0 ��A B�0�:-� 1�W�� $J�1

ii -Feng Zou

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 4: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� WX

�*�6$% ���0.�E K�L�( 9 /� 3$6 <� �aj �� ��!6 b4-

���� ��A B�0�:-� 1 '��*2 .-U� 3$6 �� �� �"�T0�j6 �� �

���� ���Z�� K�L�( 9 /� �� ���$-��*+��Z7 �� �&; � 9�� -

�T0�j6 <1� .�7��T�� aj cZJ I!h B�0�:-� aj

b �'�� '��*2�6I�� ����� U�� ��h1 �� ��6� I%R2 �� �6�

�6 b �'�� '�- ��A '��*2 aj �B�0�:-� aj$�� .��

�T0�j6�1����� w�" �� .�i3��� b-���&�7 1I��2�

M�6 K�L �( 9 /� �� �� � �7)Q����L �� .�0�� $��� (

�6 � R�"$-$%���Z7 �� �� ��A $;� b �'�� �T0�j6 9�#7 .

$-��� ��#-��0�J �� �� I�:- ��@( B�0�:-� ��'�6 ��

97 <��;� �1�2 ��� �"U�� ��;L.�Q^��1 ����Z*��6 3�T0�j6

<$6 ��HFD-STZ����2 3��� $-� ���� U�� ��h1 �� 1

��"U�� B�0�:-� aj ���A '��*2 ajS,�g,�S B� �(�"W\ u�X�

97ajN,W �1�2 ��$7�% ��M��'2���� $-� �� �,�:� ��

��01� `J��6 iI�� �)B�0�:-� .U�� aj (`J��6 �

����#�( I�� � .)B�0�:-� B� �( aj (I� ��%��.W\ �7 ��

�*J�6 1������ ��h1 ��:�*2�t�7���01� `J��6 �� �6� .

`J��6 �� �`��46 �� I� �"U�� B�0�:-� aj I�� �

B� �( � �T�� B�0�:-� aj ����#�(I� �".W�

�"�4�45" '���6 �~�� ��� � ����� 3�-���J �0��T6 .�R�

�6 ��!" k��( )�� ?���A I��% ��.��,�( �� 1 $;;� .�7

�-�1 $��� ��$46 �� $% _�#6 ����2 3���

�[ 3��$�7����QS="1�( �B�Q/S���L ������ �g/g�

I�� �ii ��-$T6 `�&6 1 B�6�� 1 `�&6 1N/E$��� )�2

I� ..�R� �� ���L ���� ���e� �� I%�� �h�" $ �� �6�

�B�6�� 1 $;-�6 .R�6 ���6 � � �$% s��� r+�� �0��T6

�6 B�="1�( 1 �-$T6 ���6��% .'�- .R�6 ���6 B � B ����;�

�� ��%��$46 k�� �� �� ��0��T6 9 /�$���6 9 /� ��

���e� ��-$-�% .�R� �� �$% ���e� �� `�� B�6�� 1 `�&6

.��$!,- C ��" .�h �� $ ����% ��!" 1�-�&6 �� '�- �R� .

���2 3��� 9� ��- ��.WW � �& �6[ 1 � �(1�� .�7��#�

�-PPT0�j6 )�D-� .��� 'PPP3��� ��PPPL �( .�RPPPP K�

���6[ 3��� �� ���9 /� H��-� .�7$��� �� K�L�( .�7

�6 ����� �� ���L d*��6$;���6 ���Z��$;;�.

��'�6 31�Z�6 .�1$J �" K�L �( � �R� 9 /� ���L

9 /� 1 I� �� .�7\�� ���L �� ���� �� .�0�� $���

i- Hiroshi Karasawa ii- moisture iii- Harlan

K�L 9� � �R� 9 /� ���;+(LFD)iv�9 /� �� .�7Q\uWQ

K�L�( � �R� 9 /� ���;+ �� ���L �� ���� �� .�0�� $���

(HFD)v9 /� 1�� b�� �� .�7Q\�� ���� �� .�0�� $���

;+ �� ���L �� K�L �*�A � �R� 9 /� ���vi(VHFD) ��

�6 ����2 ��-$-�%.WE �( 9 /� �� '�- ���L v�40� .��� K�L

�6 ���Z�� �� � �R� 9 /� C I� �$% _�#6 1 ��%E\

�"g\�6 ���L �� ���� �� .�0�� $��� ��D � r+�� $-��"

B�0�:-� �� I61�46 ��&�0����6 3U@�A� ����LWQI�� � 1

H�-�<$6 �� �-���J .�7��%.�Q�1���� 1 3�� ��[

9!6 ��!" .��� 3��$�7���� ^��;6 B �" i$;�:7 K�L�( 9 /�

�6 3�� ��[ ��$%�� .�"�p�6 q���" $-��"�WW 9 /� C �� �

�6 �1���� �� �;� � �R� ���L aj b �'�� r+�� $-��"

.$�� 3�T �e ���AWg z; 1��% .��*� .�7.WS

�6 ���L d*��6 H��-�y�( $;-��" i�7 �� �"1�Z�6

$;;� ��D � B�0�:-� �� I��:J 1 '��*2 ����=6�7.WX .���

�6 K�L�( 9 /� ���L B�6{"���L �� ���" 1 �-���J .�7

97 1 ��� ���Z�� �7��2 b7�� �� .��2�*h I!h B�;L

�6 K�L�( 9 /� B�="1�(�� �� ���" � � 1 ��% ���( �B���

�� ���Z���.W� B�� B � ����6 B������; '2 $-��"q�;6 .-

$%�� .�"��;�6[ q���" �� � `��&" �[ .$��I� �� 1

k��� �� ��J��I� B�="1�( � � �� I�:- 1�7��; '7 -

���� �;� �( .��$;;� �1$56 `6�+ �!;" �01 ���� B� �( �[ .

$�� aj7PPP;�6[ .�PP2�2 �PPP��������mA ��

B��:�/I� B�=�:�.`&#6 B � `J .�����6�� ���"

DLu��� ���Z�� B�-���6�� ��L�6 ��� �$� w�56 �� $-��"

.��2�*h �;�6[$�� B � ����� �� 1 �$% ` $�" B�=�:�

$;�.WW �� �� ���7 <1$h ����6 �$ � '�-��1$56 ���% .

K�L�( 9 /� �� B�="1�( �� .�0�� $�����\uW$���

I� 3��$�7���� .��� ��1$56 B � �01��'�6 �� 1 ��#�� 1

X/QNuWQI� $��� .�� K�L�( 9 /� 3�����" ��'�6 ��

�6 3�T0�j6���:-�� �� $��!� ���"./�-� .9 /� .��� `�

T6 �1$J �0��W\\\ 1 �R� )�2 �*�� �7 .��� .�0�� �*��

�1$J ��'�6 B � K�L �( 9 /� .���Q\\\ .��� .�0�� �*��

�R� )�2 �*�� �7I� .

�7\\ )�2 k��( )�� ?���A�QS)�2 3��$�7���� �

Q/S)�2 1 B�="1�(�)�2 ���L���� .�� B � �� �h�" ��

iv- Low-fat diets v -High-fat diets vi -Very high-fat diets

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 5: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

WN �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

�1$J B�="1�( )�2 �7E.�0�� �*�� 3��$�7���� )�2 �7 �

�1$JE�1$J ���L )�2 �7 1 .�0�� �*��N.�0�� �*��

���� ./�-�F�(QS�1$J 3��$�7���� )�2��X �*��

�.�0���)�2 �1$J ���LX1 .�0�� �*��Q/S)�2

�1$J B�="1�(S\I%�� $7��A ./�-� .�0�� �*��.�(\\

I��% �0��T6 .�R� )�2 ?���A �k��( )�� �J.1Wg

�.�0�� �*�)��X+S\+X(I� ./�-� .�0�� $��� ��

B�="1�( �� ���� ����3��$�7���� �$���/S�1 $���

���LS/Q��� $7��A $���.

<1$h�uK�L�( 9 /� 1 �0��T6 9 /� 3�����" .�0�� $���

�0��T6 9 /� K�L�( 9 /� ^�;6

B�="1�( ���L 3��$�7���� B�="1�( ���L ����3��$�7

�\ \ S\ �\ EQ WQ �\

�X � g\ �\ WX E� SE

�/�EW/\Q/gQ/�\/�\X/QNSN

�� \ g\ W WS Q\ WN

�g � g� X E\ E� �E

W/�WN/QX/S\�Q QX S S�

�� � gg WQ g\ QE\

�X � g\ X E\ E S

��!" I!h ��A ��,# �6�[ �� �6.�� K�L�( 9 /�QN

$%�� ���L �� �[ ���� �� .�0�� $�����-���J ��� ��

�6 ���Z�� �B�="1�( aj b7�� �� .��2�*h I!h 1 9�;�

�;�6[ $�� 1 B����� b7�� �� .��2�*h I!h 1 B�-���6 .

B�6�� 1 1 �-$T6 ���6 ��$46`�&6 ��7 �R� �� �� � ���6 .�7

�6 ���e�9�;� .��� B � .����\\\ �0��T6 .�R� ���( )�2

)k��( )�� ?���A I��%(�E���-$T6 `�&6 )�2S)�2

�B�6�� 1�Q �B����� )�2W1 B�-���6 )�2QW �� ��� )�2

�6 q���" 97 �� 97 .1� �� 9�;�S\X �6 )�2��% .q���"

`�&6 1� �7 � ��46 1<1$h �� �-$T6 1 �;�6�� 1 .�7W1E

I� �$% ���1[.

<1$hWu� ��46 1 3�����" �-$T6 `�&6)�*�6 �7 �� )�2\\\ `�&6 )�2(

B�0�� �6 B7[ .1� ';,;6 9���( )��;* $ 9 '�;6 9�:*� �Z:�

�E\\\ �E\ �X\\ gQ\ XX\ \\\\\ W\ W\\\\ SQ\\\ X\\\\

� �D-[ �� .1�J ��A �0��T6 .�R� ���( ��QS\ )�2

�3��$�7����SQ �="1�( )�2 1 B�\���L )�2 �� �I�

I%�� 9�7��A � ��46 B � ���� ���e�:

:3��$�7���� QS\+\ = )�2QS\

:���L �\+QW = )�2QQ

:B�="1�( SQ+�Q = )�2W\\

� .��� ��( 9 /� 3�����" �-�1 $��� ���1[ I�

B�="1�( ���6 �� �K�L��2�S\X ��R� )�2 i1�J W\\ )�2

�� �( $%�� B�="1�(\\ ��R� )�2Q/SB�="1�( )�2

.��� � ��46 B � q�"�" B��7 �� 1 I%�� 9�7��A

3��$�7����W/WW���L .��� 1W/W���� $7��A ..��� <�J

�����:-�� ���1[ I� .�� ���L �-�1 $��� �`� ./�-�

�$+ ��N�$+ �� �� B�="1�( 1 3��$�7���� �-�1 $��� 1

E�6 K�e� .�0�� 1 9�;� �I� 97 �� �� )�$� �7 �� �$6[

��$46 �� �� `� .�0�� 1 ���� ^�hN/ENE .��� .�0�� �*��

\\ � �R� )�2ENEN �R� �*�� C .��� I����6 I� -

9 �1[ .

W/WW:3��$�7���� × E = i�0���*��E/WW

W/W�:���L × N = i�0���*��W/�N

i�0���*��S\=E×Q/S:B�="1�(

�h�" �� ���� 3���56 �� �� �2�N/ENE �.�0���*��

��$46W/�N $%�� ���L �� .�0���*����7 ��\\ �*��

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 6: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� E\

.�0���X/QX�� �4" � QN���L �� ���� �� .�0�� $���

�1$J B�="1�( .��� � ��46 B � q�"�" B � �� 1 ��� $7��A

Q/E3��$�7���� .��� 1 $���Q/�S��� $7��A $���

)<1$hQ.(

<1$hEu�7 �� �;�6�� 1 `�&6� ��46 1 3�����"\\\ `�&6 )�2

B�6�� 1AQX\\\\ B�� $J�1 �**�0�

B�6�� 1D3W\\\\\ B�� $J�1 �**�0�

B�6�� 1EWQ\\ B�� $J�1 �**�0�

B�6�� 1K3Q\\\ �*�6 )�2 B�6�� 1B1�X\\ �*�6 )�2 B�6�� 1B2X\\ �*�6 )�2 B�6�� 1B3�\\ �*�6 )�2 B�6�� 1B5g\\ �*�6 )�2 B�6�� 1B6E\\ �*�6 )�2 B�6�� 1B9W\\ �*�6 )�2 B�6�� 1B12Q�*�6 )�2 B�6�� 1H2WX �*�6 )�2

9�:*� 3�;��� �SQ\\\ �*�6 )�2 ��$�:�� ��-[ Q\\\ �*�6 )�2

K�L�( 9 /� H1�% �� $T� ��Z7 1� ��6 ��,# �6�[ ��

h B�0�:-� aj �1$J �'��*2 �T�� aj cZJ I!\�

��'�6 1 ��� ���� b �'�� � �( aj �� I�:- $���

HOMA-IR �� '�-QS/���XX/gb �'�� C �� ��� �$��

S/��6 ��#- �� .�����$7���*+ B � 9�� '��*2 aj ��

;T6 ��'�6 �� ��A���� �����- b �'�� .��� .�� $T� ��Z7 C

s �'"STZ�aj b �'�� '��*2 aj 1 b7�� B�0�:-�

��'�6 1 I�� HOMA-IR ��N/X$��)��L ��;7 Y ��-

I� �$#-(.

�� �$% ���6[ .�R�$.�6� ��E��-� �h�� ���2

�� b�� 3$6 �� $%�� ���� �2� 1 ��% .��$!,-W���A� ��6

��%�.�6� �� $ ���\u�"X\u��-� �h�� .��$!,- ���2

���2.WW

<1$hQuK�L�( 9 /� 1 �0��T6 9 /� .�0�� $��� 1 �-�1 $���

3�����" �0��T6 9 /� �-�1 $��� $����0��T6 9 /� .�0�� K�L�( 9 /� �-�1 $��� K�L�( 9 /� .�0�� $���

3��$�7���� QS /S�W/WWQ/�S

���L �g/QW/W�X/QX

B�="1�( Q/S/��Q/SQ/E

1 B�6�� 1 `�&6

�-$T6

N/EuS/Qu

���� g/guN/Wu

I�� � � u/Su

^�h \\ \\ \\ \\

�1�STZ �40� ��i$6���� � <

d*��6 .�7�1�STZ �40� ��i���� � <$6HFD-STZ

����2 ���� �T0�j6 ���6 .�7�1� �� I� �$% _�#6 1 $-�

U��)�� ��#��gQ�*�6�$� ��1 )�2�*�� �7 .��� �� )�2 (1

w��6)QQuE\�*�6�$� ��1 )�2�*�� �7 .��� �� )�2 (

�40� r+��iH�- I�� ��6$-�%.g.�7�1� �� �j��� ��

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 7: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

E �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

B� �( STZ )�� ����WQ�*�6 ��1 )�2�*�� �7 .��� �� )�2

�$�(����� ��h1 �n��;�6 3�T0�j6.�*+���Z�� 9�� .

�1� �� B�4456Q�*�6 �$� ��1 )�2�*�� �7 .��� �� )�2

�40� �K�L�( 9 /� �� 3�-���J �� ��A $;� b �'�� .���i�[

1 ���� ���- �-U� ��6� � 1��� 3�����" ���� .��� ��J

��6�� �$;;� ���T6 I�� �I:�-.WN�T0�j6 �� 1 z-�� .

-���&�7�bs �'" STZ ��.�7�1�WQ�W\��Q 1EQ�*�6 )�2

�� $T� �$� ��1 )�2�*�� �7 .��� ��E�( 9 /� �� � R�" ��Z7

K�L��40� r+�� q�"�" ��i�� I�� �\�WQ�E\1\\

M�6 $���� ��5� .�7�.U�� .��%�- '��*2 ��E\

�*�6 �*�6 $� �� )�2 $% ���0.N B � �� ���3�T0�j6 �~�� ��

.�7�1�WQuW\�*�6 �$� ��1 )�2�*�� �7 .��� �� )�2

���� ���Z��$-���T0�j6 �6� 1 ��m;6 w�" �� .�

)�D-� b-���&�7$%�1� ��J �� ��� ��#-W\�*�6 �� )�2

�$� ��1 )�2�*�� �7 i����[��28 1 H�- I�� � .�7��

�6 ��#- b7�� ���A $;� $ $% b �'�� �� �D;6 1 $7�

-��6 �$� ��1 1 B�0�:��%��1� �� �� �0�J ���Q

�*�6 �$� ��1 )�2�*�� �7 i��� �� )�2 b �'�� 1 $;�

���- $ $% ��A B�0�:-� <1��:*� b �'�� 1 ���L r+�� 1

�28 1 ���7 �� $% ��A H�- I�� � .�7�<$6 � � �� �7

�6$%��.E\ �1� B ��!� K���-� .���STZ �28 1 �� .�7

H�- I�� ��$%�� ��%�� ���$ �� 1 3�-���J �;h �B ���1

6� s �'" ��STZ I��2 ��- �� ��FM�6 �� ��L .�7

�<� ����� .���(�([ $e I�0�T� I*+ �� ���6 � ��5�

�� .���� I��:JSTZ $-���.E 97B�;L�9DJ b �'��

<�*�6 �$�( �6��� ��1 1 B b �'�� �� ��� .�7 �� 1 $;�

�1��\ �6 �Z� I0�J C �� �2$-�$�.E� ��+ <�

<�* �1$J � ��5� M�6 �� ��� .�7QX�1�I� 1

�A�L��:7[ �0�* .�1$J �� .�N/E$-��� I+�.9DJ

<�*�� ��� .�7 ��*� �" $0�" ��6�Qu��6 ��2�'� ����� -

�1$J 1 ��%N\<�* $���� ��5� M�6 .��� .�7�\

I� �$% `�&#" $0�" �� $T� ��Z7.EW �1� �" k��&-�( ��1

�Q �2$-��M�6 B��I:�- 31�Z�6 ���6 1 �- � ��5� .�7�

9#L �� �� �[ ��1 �- �;h �� �1�6 �� �6� b �'�� .��2

�6$�� ��0�J �� ��6��7 I�*� ��<�* $��� 1 �7 .�7

��- .����" �2$-� <� �� �;h 1� B�� � �'h$;�.E�

97 B�;L�s �'"STZ I+� ��g� I�:- I+� �Xa��

I� �"�p�6.EE �� 1 <$6 B � �� ����2 3��� 3�T0�j6 s�

<1$h �� �h�"g�1� �WQuW\�*�6 )�2�*�� �7 .��� �� )�2

�$� ��1 �6$%�� ���;6 �1� $-��".

s �'" M1�STZ �� <��T6 �� �� ���Z� `A�� s �

.$ �1 `A�� 1I�.E v�40� I�� � �� I� �$% _�#6

s �'" s � �� �$%STZ .$ �1 `A�� 3��� ��

.��2$-�6 .��#������ ���&" `��� 1I�.EQ`A�� s �'" �6�

I� .$ �1I� ���� 3��!6 �� ���- 1.E

���� � <$6 �� �R� I�� �� 1 �$� ��1 3�����"HFD-STZ

��%R2 3�T0�j6�3�����" ���6 �� �� �n��;�6 Y ��-

���� � <$6 �� �$� ��1HFD-STZ���� ��#-$-� .�6�

�[ �� .���:� 9 /� H1�% <��-� �� �$� ��1 b �'�� �� �7

s �'" �� �( �[ b7�� 1 K�L�(STZ ��- ��Z"�

$-���.g,��,WN �����; �ib-���&�7 19 /� �� $-��� ��#-

�6 �$� ��1 b �'�� r+�� �$��� �� � �!;" �� K�L�(��%�

�01 s �'"STZ 9#L �� ���6 b7�� �� �[ .��2$7�F�6�

B� �( .�7�1�STZ ��- �$� ��1 b7�� r+�� �� �$-�%

J �$� ��1 �� .�� 1 K�L�( 9 /� �� ���� � 3�-���STZ

�1�2 �� �"U�� ��;|�7$7�% ���.gz-�1ii �� b-���&�7 1

�T0�j6��A .��;T6 31�Z" 9 /� �� 3�-���J ��1 �� �� .���

s �'" �01 $-��&- �$7�#6 K�L�( 1 �0��T6 � �R�STZ ��

��'�6W\�*�6 $J �" ��$� ��1 )�2�*�� �7 .��� �� )�2

��� b7�� �� �$� ��1 .�� � .�T0�j6 B � ����/ ���� .�7

M�6 �� B��&-�t �[ 1 B��t0 b �'�� ���� � � ��5� .�7

97 �,-��� �� ��� ���� ���L IA� 1 $�0�" B�� �-�6�FI�

3�-���J �$� ��1 ����- 31�Z�6 `�0� �0{:6 B��7 $ �% ��

$%�� �T0�j6 B �.E

;" B ����� ��h1 '�- �R� I�� �� �� ���.�A��

���� � 3�-���J �� �� K�L�( .�R� I�� �� b �'�� 3�T0�j6

���� ��#-$-�N,Eg �R� I�� �� b7�� ��h1 �� '�- �A�� �� 1

s �'" �� $T� �1� $;LSTZ B�� �R� �,�Z7 I�� �� B�,-��6 �

�1�2 �7���- 31�Z�6.�\ <1$hg��mA3�� ���� � <$6 B �

�6 ��#- ��$7�.

i- Srinivasan ii -Wang

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 8: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� E�

<1$hgu���� � <$6 �� �$% )�D-� 3�T0�j6 3����mA*HFD-STZ �- � ��5� M�6 ��

����J ��8- �$� ��1

))�2(

3�����"

��1

9 /� 3$6

K�L�()��Z7(

K�L�( 9 /� 3$6

�� `�� STZ

)��Z7(

���L $���

� �R� 9 /�

��'�6STZ )�*�6 )�2

�� .��� �� ��1 )�2�*

�$�(

��A '��*2)�*�6 �� )�2

�*�6 $� ���0(

.��2 ���$-� ��6�

��A '��*2)�� $T�

s �'"STZ(

^�;6

���t�

�01��

X\ug\ ↑W�QX QQ �EQ�WQ��*W\\S�1� g

���: 1 N\uS\ ↑�E gg\ WQ S/SQ±/WNX 1g��Z7 \

���t�

�01��

\±Ng ↔W�gS�\�W\ *

W\\

NREg

���: 1 �±�\\ ↑N�EQWQ)� ��Z7:E/Xg

9!- ��Z7 :WWE

��Z7W1N�\

���: 1 �\±�Q\ ↑XXNR W\�Q\ �\\>���Z7 �

���: 1 Q±�W\ ↔WWg\WQW\\>W�1� SS

���t�

�01��

W\\u�Q\ NR E�QX WQ

��\>

���Z7 S�

���: 1 �Q\u�\\ ↔EE��EQ�WQ�W\��QE/E\X��Z7 N

���t�

�01��

�Q\u�\\ NRE�/��WWQ�\\>W�1� XE

���: 1 �\\uQ\ ↓��QX WQ �\\W1��gQ

���: 1 �\\uX\ NR ��E\ E\ E\>g�1� gN

���t�

�01��

��\u�\\ ↓��E� E\ E\>W�1� SE

���t�

�01��

\±��\ NR gg�\ WQ X/NNE��Z7 SW

���t�

�01��

�Q\u��\ NR XXQX �Q X/NN NR�W

���t�

�01��

�\\uSQ ↓QQg\ WQ�QQ

#

*

�Q\>

�"���Z7

���6 ��

��

���t�

�01��

��\u�\\ NR NXX/QN�Q X/NNS�1� SN

���t�

�01��

�\±�Q\ ↑XXW\ Q

#

��� $T� �1�

��� $T� ��6

�1 �1����6 WN

���: 1 \±N\ NR ��E\ WQ �\\S�1� �N

���: 1 �\±Q\ NR ��QX WQ W\\u�Q\\ �1� W

���t�

�01��

�\\uX\ ↑XXg\ �Q �/WXQ ��6 gg

���: 1 \±X\ ↑W��Q E\ �Q\>Q�1� �S

���t�

�01��

��\uX\ NR SgW\ �gS�1� gS

���t�

�01��

�Q\u�\\ ↓��E\ E\ E\>$T� 1 `�� �E

���: 1 �\\ug\ NR ��E\ E\ E\>g�1� XQ

���t�

�01��

X\uQ\ ↑� � X/QXW\�WQ W\\W�1� �g

���: 1 S±�g\ ↓W�g\ Q��\

�Q�W\

*

g/�Eg �g/W\N ��/W\E �

X/EQ

S�1� E\

HFD-STZ* :�B�1���(��� P K�L�( 9 /�↓)b7��(�↑)b �'�(�↔)�;T6 )$+ 1�2 �� .���<��;� �(�NR)�$#- M��'2(�) *��%�- ���(3�T0�j6 �6��" �� �STZ �$% s �'" ���Z� `A�� 3��� ��

I6@+ �� �,6 #$%�� �$% _�#6.

���� � <$6 �� B�0�:-� �� I61�46HFD-STZ�'��*2 ����=6�7 <��;� �� B�0�:-�IA� ���A� 1.

�B�="1�( 1 ���L 1���� b4- <�* ' ��" 1 $%�.ES,EX

s � �� �;�0�:-� <�;,�W�6 <�4�-� �*�� ��:6$�� :

��:6 Akt/protein kinase B )PKB(.���:� <�=:6 ��

I� �$� �� 1 IA� .�7$; ��� �����:6"1�(��;�� B�=

�/���6 �� �$% <�T�i)MAPK(�/ �A�� ���� 9��;" �� �� -

i -Mitogen-activated protein kinase

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 9: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

EW �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

��t�0�Z:� ��:6 1 ���� b4- ' ��" 1 $%� �� �7 iCγ

)PLCγ(.EN

�$-��2 �� B�0�:-� �� �6�,;7�6 `m�6 M���%���

s � ���@ �Z:� �$-��2 .���:�� .B�0�:-�u�ii)IRS-

�ii)IRS-1(qh�6 ` $�"�Z:� �$% <�T�<�� ��; �.�" -

��;��iii)PI3K(�61 ��%PI3K�`��#" ��6��( � �-�p �t�0 .$

` $�"�Z:�<�� ��; �.�"3�Z:�iv)PIP3(�6 '�0�"�� ��1 $;�

�t PIP3�6�$% <�T� �� �D;Akt/PKB �6��%.Q\�(

�.�� <�T� ��Akt/PKB �;T ��A .���:��AS160v

�$% <�T� 1 �[ �$% <�T���� r+�� 1 ���� �* �Z:� ��

Rab-GTPase �6���%AS160 ��* �Z:� ��� `&% ��

Rab-GTPase <�4�-� �� 1 ��%�� �,- <�T� ��� `&% �� ��

`��- '��*2 uEvi)GLUT-4(<�* .�#� �� �*n+ .�7

�6 .��2�*h ��*&�$;��Q ��!6 �6�AS160 w�"

Akt/PKB <�4�-� r+�� �GLUT-4 '��*2 �1�1 1 v�#� ��

�6 <�* ����%.Q�,QW

Akt/PKB 97�0�* `A�� aj b7�� �� B�;L

cAMP �� ���L 9:�0����6 ���!6 �6$;�QE 1�*n+ ��

��*&� �����@ ��Z:� 1<�T� ��� �������; �/�&�*2

��;��Wvii)GSK3(�IA� 6 I �4" �� �/�&�*2�;�PPPPP$.

�*J�6 �� I� �� '-[ ����; �/�&�*2 .�-� �(IA�

�6 '�0�"�� �� �/�&�*2 �*�� .���:�� 1 $;�GSK3

I�.QQ �'��*2 .�� ���A� I �4" �� �1@+Akt/PKB ��

��:7 .�4� �� �D;6 .���(�([ b�( `6��+ ��!6 �� <�* .

�6 <�*��%.

z;�0�;,� ��:6 ��MAPK �IRS �$% <�T� r+��

�$-��2 �� �$-�% $-�� B�="1�( $%� ������ .u��;T

)GRB2(viii �6�� ��% C �� �� I� .���(��[ B�="1�(

���h �������$;;� �hB�-��2 .�;T $�"�=*��-ix)SOS(��

I� f��"�� .SOS .� B ��-��2 ` $�" ���� '�0�"�� ��

3�Z:�xB ��-��2 ��.�"3�Z:�xi �$% <�T� r+��xiiRas

i -Phospholipase Cγii -Insulin receptor substrates-1 iii -Phosphatidylinositol-3 kinase iv -Phosphatidylinositol trisphosphate v -Akt substrate of 160 kDa vi-Glucose transporter, type 4 vii-Glycogen synthase kinase 3 viii -Growth factor receptor-bound protein 2 ix-Son-of sevenless x-Guanosine 2 phosphate xi-Guanosine 3 phosphate xii -Rat sarcoma

�6���- �� '�- �[ 1 ��% ��A .xiiiRaf .��;�� I�0�T� �� ��

������6 <�T�$;�FRaf <�T� ��;�� �$% �* �Z:� r+��

�$;;� .MAPK �;T xivMEK �6* �Z:� �� �� ��%PPP �

����MAPK�6 <�T� �� �[ �$;�FMAPK �� �* �Z:�

.����� ��:- .�7������ .1� �p� �� ��:7��1�� r+��

�6 B�0�:-� C�-/���6 3��p���%.Qg

PLC��*�1 iB�="1�(G<�T��6��% �� �D;6 1

� ��; � $�0�"PPPP<�.�"Z:�PPP3�xv)IP3(.� 1�[PPPPPP`-

<1�:�*2xvi)DAG(�6��% .aj b �'��IP3 1DAG ��

`�+ � �-�p ��6��( ���;+ �� 9@(����6$;� b �'�� �� 1

B�="1�( �$% <�T� �� �D;6 �0�* `A�� 9�:*� aj

��;��xviiC)PKC(�6��%.QS PKC `��$J�' ���6 )��1' �

�� 1 ���� ' ���6W8 1 �� �1�2� ��21 �&���0�"�� .�7

�6 9�:4" 31�Z�6 ����;"$-�%.QX

PKC I� B&�6Ras ��:6 1Raf- MEK -MAPK

<�T� ��$;�QN � 1Raf �� `4�:6 �� �� ��Ras <�T�

$;�.g\,g z;�0�;,� ��:6 `&% �� B�0�:-��$% ��@A

I�.

���$-� �� �[ � �-��" � B�0�:-� aj �� �-�6� $%��- .�

<�* �� �� �T�� �;�0�:-� y�( $-���� �" ����L I��� .�7

$;� ��D � .$�� 1 �-@n+�Z"� B�0�:-� �� I61�46�6 �� -

$���.g� 9:�-�&6 �L �2� �� B�0�:-� �� I61�46 �� `�A� .�7

I:�- _�#6 `6�� �� �9 /� �� I� �$% )�*T6 �6�

�A�� �$% ��%��-� �� �D;6 K�L�( 1 $�6�� ���- �7$�t�0

.�`�[I���6 �� <1�:�*2 ��:6 1 �$% �7IRS-1/

PI3-K/AKT ��!6 �� ���� <�4�-� <@�A� r+�� 1GLUT4

<�* .�#� ���6��% 3@n+ w�" '��*2 I%���� 1

b7�� �� ��*&��6$7�.gW,gE

�, � �0���J� 9:�-�&6��A�L �� <@�A�'��*2 .u

K�L$��I� .���� b �'�� aj.�" .`�0� �� $ �:�*2

����$�:�� 1 ���� k��� �� ����L l�m6 .�7$��

�6 b �'�� �� K�L$7�F�-@n+ 1 .$�� I%���� B ����;�

�j�1 �� '��*2 .cZJ I!h �$� 1 ���� b7�� B�0�:-�

��1$56 �� '��*2 aj b �'�� �� B�0�:-� a%�" ��T�� .

xiii -Rat fibrosarcoma xiv - Mitogen-activated/extracellular signal–regulated kinase xv-Inositol 3-triphosphate xvi-Diacylglycerol xvii-Protein kinase C

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 10: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� EE

�6$7�F1� B � ���B� �( .�7�1� ��JSTZ �6��&*�+ $-��"

<�*$;� `��6 �� ��� .�7.X

� � 3�����"I��� ���� � <$6 �� �7HFD-STZ

�40�i� I�� � ��j�1 1 K�L�( 9 /� .STZ �6$-��"

I��� .1����R,� �p� '�- �, � .�7 .<�~6 .����r+�� ��*� ��

���1 b �'����,gQ I6��e 1 <� 8-�'6 �& �"�6 b �'��

�#� B�0��7 ��1�*&��01�6�*2 ��01�6�*2 � �( .

�6 �01�6�*2 ��1�"�t �7 1 �1�*&�1�"�[��%.\

`&%u1 B�0�:-� z;�0�;,� ��:6�[ �� K�L �( 9 /� �p�.

Akt/PKB, Akt/protein kinase B; ERK, Extracellular signal-regulated kinase; GRB2, Growth factor receptor-bound protein 2; HFD, high fat diet; IRS-1/2, Insulin receptor substrates-1/2; JNK, c-Jun N-terminal kinase; JNKK, c-Jun N-terminal kinase kinase; MEK, Mitogen-activated/extracellular signal–regulated kinase; MEKK-1, Mitogen-activated/extracellular signal–regulated kinase kinase 1; PLC , Phospholipase Cγ; PKC, Protein kinase C; PI3K, Phosphatidylinositol-3 kinase.

�� � '�6 �.��#�� q�[ ���� � 3�-���J ���&: � <��-�

�6 ��#- ��<�* ��'�6 1 $;7� ��t�� �� .�7W�� <�T�

��t�7��[ �6 �6 b7�� ��A�;% ��&*�+ 1 b �'�� �7$�� .gg

�$-��2 �$% 9��e 1 )�� �9#L ��&�% ���71 .��- .

<�* � U<�* � U 1 ��j�1� .�7�-�� )��*��(� .�7 �� ���

M�6�6 �$7�#6 ���� � .�7��%.gS

� ��q*�3�1��( 9 '-[ I�0�T� 1 ��*� �/�&�*2 ��'�6

b �'�� ��-/1�$�7��6�$�� �1$� q*� �e��4-� ��&*�+ �01

�6 ���� ����"$-�6.E\

�2� 1 C�"1�*&�1�"[ 3�T �e ��D � r+�� 3���[ �� -

����:2 .�7�6 ���L .��% .^�D" 1 ����" ���@( ��&*�+

�6 b �'�� �1�+ �� �� ���0 `�&#" ���@($7�.\

�$% ��1 1 ���$-� b �'�� �� �D;6 $�� ��gX ��'�6 1

9 '-[7PPPP3�"��t[ .� Z:-��"�;�6[PPPPP�-U[ ����PPPPP B

����Z:-��"�;�6[�E '��*2 1 �@ �Z:� �/�&�*2 I�0�T�gu

b �'�� ��"�Z:� �6�$�� Q�/�&�*2 ��'�6 �01gN,S\ I�0�T� 1

9 '-[���;�����*2 .�7Q,S\ -/1�$�7� 3�;�:��PPPP 1 ��

���; �/�&�*2g�6 b7��$�� .97B�;L��0�,L b �'��

Insulin

Insulin receptor

IRS-1/2

Ras

Raf MEKK-1

JNKK

JNK

MEK

ERK

PLC

PKC

HFD

Glucose uptake

GLUT4 translocation

Akt/PKB

PI3K GRB2

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 11: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

EQ �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

.�$;����6 ��-1��&0��1�&- 1 )���6 .�7 <�* �� .$�� .�7

�6 �$7�#6 ���L IA� b �'�� I*+��% .K�L .�7$��

1 ���[ K�L .�7$�� b �'�� �� �D;6 1 ���� )�D7 $�� ��

.�"�$% C �5" ����$�:�� ��� 1 �$% $ �:�*2�'�0�&�*2

�6 ��!6 ��#�� ��$;�.S 9 '-[ I�0�T� ��1@+ �� ��-[ .�7

�:�� ���"�"�*2 1 ��"��: �$�:���(� ��U�"�� $;-�6 �-�$

q�[ �� �D;6 1 ���� b7�� ����1�� �� ��"�$�:�� .�7

I����6 �7��%.gN,S�,SW

97 ��1� �/1���- ���A B�;�"[�� �B�;L .���AgN,SE

������ B�="1�(�\�C ���- $�:�� �.$�t�0 ����$�:���(

B���0��; ��Ng�* ��&�*2 B���*2��7 ��,�N,Eg 1TNF-α�N,W ��

�6 b �'�� K�L�( 9 /� �� ���� � 3�-���J$�� .

���� � <$6 �� .$�t�0 ` ��1�( 3�����"HFD-STZ

���� � <$6 ��HFD-STZ��*2 �� �1@+ 9:�0����6 �'�

�6 `��6 '�- ���L I�� � �� �� I� ���Z"� ���7 �� ��%

H�-��$7�#6 '�- �-�:-��6��% �6 1.�jA `6�+ $-��"

.����� .���$%�� ��1�+ ��*� .�7.g����2 3��� 3�T0�j6

<$6 B � �� ���Z�� ���"�����" �-�A aj ��'�6 �� �� �

.�" �<1��:*��t�0 ����[ K�L $�� �$ �:�*2 �� B�="1�(

�t�0 1 B� �( �0�,L���� ��#- U�� �0�,L �� B�="1�( -

$-�.E,g,\,�\,�,Eg,SQ �� .$�t�0 ` ��1�( �� I%�� �h�" $ �� ���0�

M�6 ��A6 1 � ��5� .�7 ��:-� �&+ M�I� aj 1

�t�0 �$ �:�*2 .�" B� �( �<1��:*� 1 9� �0�,L �� B�="1�(

�t�0 �-�A aj �01I� ��#�� �U�� �0�,L �� B�="1�(.Sg ��

s �'" ��T0�j6 C STZ �K�L�( 9 /� �1$� 1 � �!;" ��

.�" �<1��:*� aj ����" �� ���[ K�L $�� 1 $ �:�*2

��$-��7������ B � b �'�� r+�� K�L�( 9 /� �� �0�J ��

s �'" 1 $%STZ ���� b �'�� aj 3�-���J B � �� .

� 1 $ �:�*2 .�" �<1��:*���� $ $#" �� ���[ K�L $�.g,�\

���� � <$6 �� ����2 3��� 3�T0�j6 �~��HFD-STZ �

j b �'��PPP�<1��:*� �-�A aE,g,\,�\,Eg,SQ,SS .�" -

2�$ �:�*g,\,�\,Eg,SQ,SS ���[ K�L $���\,S,SS�t�0 1�� B�="1�(

B� �( �0�,LE,Eg,SQ,SS ���� M��'2 ��$-� .B&�6 b �'�� B �

I*+ �� I� �[ KRh b �'�� � �7 �9 /� l�m6 <��-�

I��� �� I%���� b7�� � 1 .$�� IA� b �'�� �K�L�( -

$%�� �j�56 .�7.g�t�0 �-�A aj �� �n��;�6 Y ��- -

�6 �$ � U�� �0�,L �� B�="1�( ��'�6 B � �A�� �� �� ��%

b �'��\���� b7�� '�- �A�� �� 1Eg,SQ ���� ����" �1$� � 1

��� �$-�6.SS �t�0 �/1��7 ������ C U�� �0�,L �� B�="1�(

�6 1 I� w ��% �A�� I5" $-��" ���A���� ��mA

I�� � $;-�6 ���!�0� w ��%�$�� ����" .SX

���� � <$6 �� �-/ ���� 3�����"HFD-STZ

�/ ����GLUT4 ���� � 3�-���J 3@n+ ��HFD-STZ 9�I� 90� 3�-���J �� �".Eg 97�/ ���� B�;LIRS-1

���� b4- B�0�:-� z;�0�;,� ��:6 �� ���1 $�� ���*� ��

���� � 3�-���J ��*&� �*n+ �6 b7��$�� .SE�$-��2 .

�$;;� <�T� .��~&" � 61� �:���(i����-�A �n+ �� .

�$-��2��:7 .�7 .�I� �� I61�46 1 K�!�0� b7�� �� �

�0�:-� �� I��:J b �'�� 1 B�0�:-����� b4- B�� �� 1

����:2�6 ���� ���L I��� �� .� �A�� '-/�"�( �� 1 ��%

.��������� b4- �1�*&�1�"[ 1 ���L �I�� � $;-�6 �7.SN

�6 b7�� ���� � 3�-���J �� B�="1�( B � �/ ����$�� .SE

B2���*2 ��% $��t(���"��-�� 9 '-[ w�"B2���*21�( ��

��1� ����A� �6��% .���� �� I� �$% _�#6

�B2���*21�(��"��-�� 9 '-[SS1B2���*2 ��% $��t(X\ ��

�6 b7�� I�� �$�� FB2���*21�( �/ ���� ���0� 9 '-[ 1

��"��-��a%�" b �'�� �� �D;6 1 b �'�� K�L�( 9 /� ��

�6 B�0�:-���%�s �'" �6�STZ b7�� 3$% �� �� �[ ����

�6$7�.SS �/ ���� ����6���NF-κB�� y�( �� ��

�<�& ������ b4- ��"�$�:�� k��� 1 ���[ .�7�.����� ��

�6 b �'�� I�� �$�� .SE B � �� �1@+�I� �$% I��p ��

�$-�� b�( `6��+ �/ ���� $;-�6 K�!�0� .TNF-α1

�; �B���0�g97 1 ���� � 3�-���J �� �/ ���� B�;LTNF-α

<$6 ���L I��� �� 3$% �� B�0�:-� �� )1�46 �&��-/ .�7

�6 b �'��$�� .SS

�T0�j6 <$6 �� I�� � ����+ .HFD-STZ

<$6HFD-STZ 6 �-U� ��6� 3$6 ���.��� $-��"

��"�(1�Z- $;-�6 I�� � ����+ ������ �"�(1��-X �( 1

��A .��#�gQ %�� $�Z6$.3��� 3�T0�j6 �� ��;|�7

�6 $� {" �� H�e�6 B � '�- ����2$;;� .�� �& �"�(1��-

^ �% I�� � ����+ B �"I� .��� �$��� �� B�4456 1

9�:-�&6 ���� �� ��2$-�h �� ���� � �"�(1��- .�7STZ

�6 ���Z��$-��� .STZ �+��- .�7��*21�&�6 b �'�� ��

�7��*21��� b7�� 1 <�T� ��� �� y�( ����" r+�� H��- ��

�6 .80[�t �7 1��%.X �� �$% ��D � .80[�t �7STZ ��

'��*2 aj �� ��� 3$% 1 I� f��"�� �� ��A $;� b �'��

i- Peroxisome proliferator-activated receptor

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 12: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� Eg

���� 9�4�:6 f��"������ b7�� r+�� B�0�:-� s �'" �� ��L

�6��%.X� � �R� 9 /� $;;� _�#6 �&; � .��� ��[ �� $T�

�6 �-�,L �� `�� ����R,� �p� ���� � �"�(1��- .1� $-��"

s �'"STZ �2$-�h �� K�L�( � �R� 9 /� �� ���Z�� �

$-��� .M�6 ���797 1 � �!;" �� K�L�( � �R� 9 /� �B�;L

����7 ��STZ���D � ��� �� y�( �-���� b �'�� r+��

M�6 �� �01 �$% �&�-�&6 ?�56 w�" �$% �� ��5� .�7

��� ����� �� �� .����" � �!;" �� K�L�( � �R� 9 /�

I%�$- ����7 �� �"���J 1 �&�-�&6����" �6� �� �[ qSTZ �

��� b �'�� �� �&�-�&6 ?�56 �� y�( �-����.X

�6 <$6 B ��40� .��� $-��"i$�Z6 '�- ���� � �"�(1�Z-

$%�����*� �� ��LM�6 .H�- ���� � � ��5� .�7�I�:-

H�- I�� � ���6 ��#- �� .�"$ $% q�[$;7���*+ 9��

B�="1�( 1 ��A '��*2 ��'�6 �&; �I� ���� ��%�����.�� ��

��, � l� b �'�� �1$� 1 � �!;" �� K�L�( � �R� 9 /�

D � qh�6 ������ B�="1�( 1 ��A $;��;T6 q�[ �� �� .���

�6 ��A ��#� b �'�� 1 ��*���%.��,gQ L��b4- �7$�t�0

�6 .��� ��*� q�[ �� ��!6 .�7/��1���6 b �'�� �� 1 $;;�

��"�$�:�� .�7������ 1 � ����% 3�����" a%�" �01�6�*2

b �'�� �� �6$;7�.���� I%�� �h�" $ �� �6�STZ ��*� .1�

'��" `6�+ B � 1 ���� C�:��" �p��e��+ �� �� �[ I�� � .

6 `&#6����.XW

�*+31�Z" 9���� �7 ��'�6 1 � �R� 9 /�STZ ���L

���� � <$6HFD-STZ �28 1 H�- I�� � .�7��-�:-��

<�* ��&*�+ <@�A� �;T �� B�0�:-� �� I61�46 1 ��� .�7

�6 ��#-$7���6H�- I�� � 3�T0�j6 .��� ���;6 <$6 $-��"

�$%�� .����� 1 ��[ <$6 B � v�40�I� �6 1�� $-��"

1��� �p� ���� H�- I�� � ��6�� �� �7�C��$%�� �$;;�.

References 1. Atkins RC,Zimmet P. Diabetic kidney disease: Act now

or pay later. J Bras Nefrol 2010; 32: 7-10. 2. Chen L, Magliano DJ, Zimmet PZ. The worldwide ep-

idemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol 2011; 8: 228-36.

3. Guariguata L, Whiting DR, Hambleton I, Beagley J, Li-nnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-49.

4. Wang HJ, Jin YX, Shen W, Neng J, Wu T, Li YJ, et al. Low dose streptozotocin (stz) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression. Asia Pac J Clin Nutr 2007; 16: 412-17.

5. Ansarullah Bhavna Bharucha P V, Ramachandran AV. Improved glucoregulation, insulin resistance and leptin levels by a polyherbal drug in high fat diet and low dose streptozotocin type 2 diabetes model. Diabetologia Cro-atica 2012; 41: 3-15.

6. Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005; 52: 313-20.

7. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, et al. A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metab-olism 2000; 49: 1390-94.

8. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25: 5-20.

9. Ghasemi A, Khalifi S, Jedi S. Streptozotocin-nicotin-amide-induced rat model of type 2 diabetes. Acta Physiol Hung 2014; 101: 408-20.

10. Doan Vie t B, Nguye n Thi Kim D, Le Thi Bich T, Nguye n Bich N, Phan Van C. Macro- and micr-ovascular complications of diabetes induced by high-fat diet and low-dose streptozotocin injection in rats model.

International Journal of Diabetes Research 2013; 2: 50-5.

11. Irons BK, Minze MG. Drug treatment of type 2 diabetes mellitus in patients for whom metformin is cont-raindicated. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014; 7: 15-24.

12. Szkudelski T. The mechanism of alloxan and strept-ozotocin action in b cells of the rat pancreas. Physiol Res 2001; 50: 537-46.

13. Islam MS, Wilson RD. Experimentally induced rodent models of type 2 diabetes. Methods Mol Biol 2012; 933: 161-74.

14. Srinivasan K, Ramarao P. Animal models in type 2 dia-betes research: An overview. Indian J Med Res 2007; 125: 451-72.

15. Masiello P. Animal models of type 2 diabetes with reduced pancreatic b-cell mass. Int J Biochem Cell Biol 2006; 38: 873-93.

16. Wilson RD, Islam MS. Fructose-fed streptozotocin-inje-cted rat: An alternative model for type 2 diabetes. Pharmacol Rep 2012; 64: 129-39.

17. Novelli M, Fabregat M E, Fernandez-Alvarez J, Gomis R, Masiello P. Metabolic and functional studies on iso-lated islets in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2001; 175: 57-66.

18. Novelli M, Pocai A, Lajoix A D, Beffy P, Bezzi D, Marchetti P, et al. Alteration of b-cell constitutive no synthase activity is involved in the abnormal insulin response to arginine in a new rat model of type 2 diabetes. Mol Cell Endocrinol 2004; 219: 77-82.

19. Zhang M, Lv XY, Li J, Xu ZG, Chen L. The char-acterization of high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model. Exp Diabetes Res 2008; 2008: 704045.

20. Atanasovska E, Tasic V, Slaninka-Miceska M, Alabak-ovska S, Zafirov D, Kostova E, et al. Six week follow-up of metabolic effects induced by a high-fat diet and streptozotocin in a rodent model of type 2 diabetes mellitus. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2014; 35: 169-79.

21. Lu HE, Jian CH, Chen SF, Chen TM, Lee ST, Chang CS, et al. Hypoglycaemic effects of fermented mycelium

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 13: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

ES �� �� �� ����� !�" �# �$%&��'&(#�(%��� ���� ) � �� *&+ ,����-. /&� �� 0 � 12�3 ��&% �4���5 �

of paecilomyces farinosus (G30801) on high-fat fed rats with streptozotocin-induced diabetes. Indian J Med Res 2010; 131: 696-701.

22. Danda RS, Habiba NM, Rincon-Choles H, Bhandari BK, Barnes JL, Abboud HE, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int 2005; 68: 2562-71.

23. Zou F, Mao XQ, Wang N, Liu J, Ou-Yang JP. Astr-agalus polysaccharides alleviates glucose toxicity and restores glucose homeostasis in diabetic states via acti-vation of ampk. Acta Pharmacol Sin 2009; 30: 1607-15.

24. Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, et al. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: The fat-fed, streptozotocin-treated rat. Metab-olism 2007; 56: 1233-40.

25. Karasawa H, Nagata-Goto S, Takaishi K, Kumagae Y. A novel model of type 2 diabetes mellitus based on obesity induced by high-fat diet in bdf1 mice. Metabolism 2009; 58: 296-303.

26. Hu SH, Jiang T, Yang SS, Yang Y. Pioglitazone am-eliorates intracerebral insulin resistance and tau-protein hyperphosphorylation in rats with type 2 diabetes. Exp Clin Endocrinol Diabetes 2013; 121: 220-4.

27. Gandhi GR, Stalin A, Balakrishna K, Ignacimuthu S, Paulraj MG, Vishal R. Insulin sensitization via partial agonism of pparγ and glucose uptake through translo-cation and activation of glut4 in pi3k/p-akt signaling pathway by embelin in type 2 diabetic rats. Biochim Biophys Acta 2013; 1830: 2243-55.

28. Khan HB, Vinayagam KS, Moorthy BT, Palanivelu S, Panchanatham S. Anti-inflammatory and anti-hyper-lipidemic effect of semecarpus anacardium in a high fat diet: Stz-induced type 2 diabetic rat model. Inflam-mopharmacology 2013; 21: 37-46.

29. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 2012; 26: 483-90.

30. Albersen M, Lin G, Fandel TM, Zhang H, Qiu X, Lin CS, et al. Functional, metabolic, and morphologic chara-cteristics of a novel rat model of type 2 diabetes-associated erectile dysfunction. Urology 2011; 78: 476.e1-8.

31. Abo-elmatty DM, Essawy SS, Badr JM, Sterner O. Ant-ioxidant and anti-inflammatory effects of urtica pilulifera extracts in type 2 diabetic rats. J Ethno-pharmacol 2013; 145: 269-77.

32. Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig 2014; 5: 349-58.

33. Reeves P G. Components of the ain-93 diets as improv-ements in the ain-76a diet. J Nutr 1997; 127: 838-41.

34. Gajda A M, Pellizzon M A, Ricci M R, Ulman E A. Diet-induced metabolic syndrome in rodent models. Animal Lab News 2007; 74: 775-93.

35. Flanagan AM, Brown JL, Santiago CA, Aad PY, Spicer LJ, Spicer MT. High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J Nutr Biochem. 2008; 19: 505-13.

36. Medinsky MA, Popp JA, Hamm TE, Dent JG. Devel-opment of hepatic lesions in male fischer-344 rats fed ain-76a purified diet. Toxicol Appl Pharmacol 1982; 62: 111-20.

37. Bergstra AE, Lemmens AG, Beynen AC. Dietary fru-ctose vs glucose stimulates nephrocalcinogenesis in female rats. J Nutr 1993; 123: 1320-7.

38. Tierney AC, Roche HM. The potential role of olive oil-derived mufa in insulin sensitivity. Mol Nutr Food Res 2007; 51: 1235-48.

39. Zhang F, Ye C, Li G, Ding W, Zhou W, Zhu H, et al. The rat model of type 2 diabetic mellitus and its glyc-ometabolism characters. Exp Anim 2003; 52: 401-7.

40. Mansor LS, Gonzalez ER, Cole MA, Tyler DJ, Beeson JH, Clarke K, et al. Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin. Cardiovasc Diabetol 2013; 12: 136.

41. Deeds MC, Anderson JM, Armstrong AS, Gastineau DA, Hiddinga HJ, Jahangir A, et al. Single dose streptozotocin induced diabetes: Considerations for stu-dy design in islet transplantation models. Lab Anim 2011; 45: 131-40.

42. Mcevoy R C. Changes in the volumes of the a-, b-, and d-cell populations in the pancreatic islets during the postnatal development of the rat. Diabetes 1981; 30: 813-7.

43. H.McNeill J.(1999). Experimental models of diabetes. 44. Candela S, Hernandez RE, Gagliardino JJ. Circadian

variation of the streptozotocin-diabetogenic effect in mice. Experientia 1979; 35: 1256-7.

45. Tay YC, Wang Y, Kairaitis L, Rangan GK, Zhang C, Harris DC. Can murine diabetic nephropathy be sep-arated from superimposed acute renal failure & quest. Kidney Int 2005; 68: 391-8.

46. Kongkachuichai RP, Surasiang R, Posuwan J, Charoe-nsiri R, Kettawan A, Vanavichit A. Effect of riceberry oil (deep purple oil; oryza sativa indica) supplem-entation on hyperglycemia and change in lipid profile in streptozotocin (stz)-induced diabetic rats fed a high fat diet. International Food Research Journal 2013; 20: 873-82.

47. Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev 2007; 28: 463-91.

48. Bogardus C, Lillioja S, Mott DM, Hollenbeck C, Rea-ven G. Relationship between degree of obesity and in vivo insulin action in man. Am J Physiol 1985; 248: 286-91.

49. Manning B D. Insulin signaling: Inositol phosphates get into the akt. Cell 2010; 143: 861-3.

50. Mora A, Komander D, van Aalten DM, Alessi DR. P-DK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 2004; 15: 161-70.

51. Sakamoto K, Holman GD. Emerging role for as160/tbc1d4 and tbc1d1 in the regulation of glut4 traffic. Am J Physiol Endocrinol Metab 2008; 295: 29-37.

52. Howlett KF, Sakamoto K, Garnham A, Cameron-Smith D, Hargreaves M. Resistance exercise and insulin reg-ulate as160 and interaction with 14-3-3 in human skeletal muscle. Diabetes 2007; 56: 1608-14.

53. Kohn AD, Summers SA, Birnbaum MJ, Roth RA. Exp-ression of a constitutively active akt ser/thr kinase in 3T3-L1adipocytes stimulates glucose uptake and gluc-ose transporter 4 translocation. J Biol Chem 1996; 271: 31372-8.

54. Kitamura T, Kitamura Y, Kuroda S, Hino Y, Ando M, Kotani K, et al. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3b by the serine-threonine kinase akt. Molecular and Cellular Biology 1999; 19: 6286-96.

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 14: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

��������,��� ������� � ��������� ���� ��� ��� �� ���������� ���� EX

55. Turban S, Hajduch E. Protein kinase c isoforms: Med-iators of reactive lipid metabolites in the development of insulin resistance. FEBS Lett 2011; 585: 269-74.

56. Molina JR, Adjei AA. The ras/raf/mapk pathway. Jou-rnal of Thoracic Oncology 2006; 1: 7-9.

57. Hiraoka M. A novel action of insulin on cardiac membr-ane. Circulation Research 2003; 92: 707-09.

58. Formisano P, Fiory F, Caruso M, Miele C, Maitan M A, Andreozzi F, et al. Insulin-activated protein kinase cb bypasses ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Molecular and Cellular Biology 2000; 20: 6323-33.

59. Schubert C, Carel K, DePaolo D, Leitner W, Draznin B. Interactions of protein kinase c with insulin signaling influence on gap and sos activities. J Biol Chem 1996; 27: 15311-4.

60. 60. Cai H, Smola U, Wixler V, Eisenmann-Tappe I, Diaz-Meco MT, Moscat J, et al. Role of diacylglycerol-regulated protein kinase c isotypes in growth factor activation of the raf-1 protein kinase. Mol Cell Biol 1997; 17: 732-41.

61. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, et al. Protein kinase c alph activates raf-1 by direct phosphorylation. Nature 1993; 364: 249-52.

62. Petersen K F, Shulman GI. Etiology of insulin resist-ance. Am J Med 2006; 119: S10-6.

63. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (irs-1)-ass-ociated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002; 277: 50230-6.

64. Samuel VT, Shulman GI. Mechanisms for insulin resis-tance: Common threads and missing links. Cell 2012; 148: 852-71.

65. Chaudhari HS, Bhandari U, Khanna G. Embelia ribes extract reduces high fat and low dose streptozotocin-induced diabetic nephrotoxicity in rats. EXCLI J 2013; 12: 858-71.

66. Zhang T, Pan BS, Zhao B, Zhang LM, Huang YL, Sun FY. Exacerbation of posrstroke dementia by type 2 diabetes is associated with synergistic increase of sec-retase activation and amyloid generation in rat brains. Neuroscience 2009; 161: 1045-56.

67. Ren Z, Li W, Zhao Q, Ma L, Zhu J. The impact of 1,25-dihydroxy vitamin D3 on the expressions of vascular endothelial growth factor and transforming growth factor-b1 in the retinas of rats with diabetes. Diabetes Res Clin Pract 2012; 98: 474-80.

68. Islam MS, Choi H, Loots du T. Effects of dietary onion (allium cepa l.) in a rodent model of high-fat diet streptozotocin-induced diabetes. Ann Nutr Metab 2008; 53: 6-12.

69. Parveen K, Khan R, Siddiqui WA. Antidiabetic effects afforded by terminalia arjuna in high fat-fed and streptozotocin-induced type 2 diabetic rats. Int J Diabetes and Metab 2011; 19: 23-33.

70. Xiao-Hui Xing Z Z, Hu XZ, Wu RQ, Xu C. Antidiabetic effects of artemisia sphaerocephala krasch. Gum, a novel food additive in china, on streptozotocin-induced type 2 diabetic rats. J Ethnopharmacol 2009; 125: 410-6.

71. Xia Y, Li Q, Zhong W, Dong J, Wang Z, Wang C. L-carnitine ameliorated fatty liver in high-calorie diet/stz-

induced type 2 diabetic mice by improving mitocho-ndrial function. Diabetol Metab Syndr 2011; 3: 31.

72. Sankar P, Subhashree S, Sudharani S Effect of trigonella foenum-graecum seed powder on the antioxidant levels of high fat diet and low dose streptozotocin induced type ii diabetic rats. Eur Rev Med Pharmacol Sci 2012; 16: 10-7.

73. Zhao H, Li Z, Tian G, Gao K, Li Z, Zhao B,et al. Effects of traditional chinese medicine on rats with type ii diabetes induced by high-fat diet and streptozotocin: A urine metabonomic study. Afr Health Sci 2013; 13: 673-81.

74. Sahin K, Tuzcu M, Orhan C, Sahin N, Kucuk O, Oz-ercan IH, et al. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin. Br J Nutr 2013; 110: 197-205.

75. Swathi M, Priyanka DS. Evaluation of antidiabetic pot-ential of marketed polyherbal formulation (ayurslim) on high fat diet-streptozotocin induced obese diabetic rats. Int J of Biological and Pharmaceutical Research 2012; 3: 524-

76. Zhang SH, Reddick RL, Burkey B, Maeda N. Diet-induced atherosclerosis in mice heterozygous and homo-zygous for apolipoprotein E gene disruption. J Clin Invest 1994; 94: 937045.

77. Singh S, Sharma RK, Malhotra S, Pothuraju R, Sha-ndilya UK. Assessment of gut associated changes and adipose tissue inflammation in high fat diet fed streptozotocin-induced diabetic rats. J of Innovative Bio 2014; 1: 68-77.

78. Van Linthout S, Spillmann F, Schultheiss HP, Tschope C. High density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des 2010; 16: 1504-1.

79. Hou L, Lian K, Yao M, Shi Y, Lu X, Fang L, et al. Reduction of n-3 pufas, specifically dha and epa, and enhancement of peroxisomal beta-oxidation in type 2 diabetic rat heart. Cardiovasc Diabetol 2012; 11: 126.

80. Drucker DJ. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 2003; 26: 2929-40.

81. Byrne FM, Cheetham S, Vickers S, Chapman V. Char-acterisation of pain responses in the high fat di-et/streptozotocin model of diabetes and the analgesic effects of antidiabetic treatments. J Diabetes Res 2015; 2015: 752481.

82. Eleazu CO, Eleazu KC, Chukwuma S, Essien UN. Re-view of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans. J Diabetes Metab Disord 2013; 12: 60.

83. Lenzen S. The mechanisms of alloxan-and streptoz-otocin-induced diabetes. Diabetologia 2008; 51: 216-26.

84. Ansuri MI, Patel VM. Evaluation of antidiabetic and antihyperlipidemic activity of euphorbia aneriifolia linn. In high fat diet- streptozotocin induced type-2 diabetic model. Int J For Pharmaceutical Research Scholars 2014; 2: 83-9.

85. Parveen K, Khan MR, Mujeeb M, Siddiqui WA Prot-ective effects of pycnogenol on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem Biol Interact 2010; 186: 219-27.

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20

Page 15: ijem.sbmu.ac.irijem.sbmu.ac.ir/article-1-2039-fa.pdf · Wg A M 2 $;; 6 R " U L R 9 / . $;7 #- $- T ' *2 01 U B0:- A b ' aj 3 -J B .IS B0:- I61 46 k L l m6 `0 $ :*2 . " . F$7 6 b '

157/Iranian Journal of Endocrinology abd Metabolism Vol 18 No.2 June-July 2016

Review Article

A Review of High Fat Diet-Streptozotocin Model for Induction of Type 2 Diabetes in Rat

Gheibi S1, Bakhtiarzadeh F2, Ghasemi A2

1Neurophysiology Research Center & Department of Physiology, Faculty of Medicine, & 2Endocrine Physiology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran,

I.R. Iran

e-mail: [email protected]

Received: 20/12/2015 Accepted: 26/04/2016

Abstract Introduction: Diabetes, one of the most common chronic diseases worldwide, has many

complications and current treatments impose a high cost on health system necessitating that newer treatments be investigated. Type 2 diabetes mellitus is the most common form of diabetes, characterized by insulin resistance and dysfunction of pancreatic beta cells. Considering the restrictions of human studies, animal models of diabetes are appropriate tools for researches. Rodents are the first choice for inducing diabetes mellitus due to their short generation time and economic considerations. There are several animal models of type 2 diabetes, of which, those with both beta cell impairment and insulin resistance are preferable. In the high fat diet-streptozotocin model, as a model of type 2 diabetes, high fat diet induces insulin resistance and streptozotocin causes partial beta cell destruction. The high fat diet-streptozotocin model is a cost-effective and appropriate model for studying type 2 diabetes. In conclusion high fat diet-streptozotocin model has metabolic characteristics similar to those of human type 2 diabetes and can be used for investigating the effects of more recent antidiabetic medications available for the condition.

Keywords: Animal model, Type 2 diabetes, Rat, High fat diet, Streptozotocin

Dow

nloa

ded

from

ijem

.sbm

u.ac

.ir a

t 8:2

8 +

0430

on

Thu

rsda

y A

ugus

t 27t

h 20

20